MARY CONTI: Open Payments
NPI 1518501220 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 91 payments from 18 companies in 2025. Trend: 2023 $1,358 · 2024 $1,818 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $300 |
| Novartis Pharmaceuticals Corporation | 21 | $218 |
| Amgen Inc. | 14 | $172 |
| Novo Nordisk Inc | 12 | $163 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $97 |
| Merck Sharp & Dohme LLC | 5 | $79 |
| HEARTFLOW, INC. | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| ABIOMED | 2 | $41 |
| Kestra Medical Technology Services, Inc. | 1 | $35 |
Products named: FARXIGA, LEQVIO, REPATHA, Wegovy, LifeVest, LOKELMA, VERQUVO, FFRct.
Industry payments across MO — which companies pay providers there.
